Somatostatin regulates tight junction proteins expression in colitis mice

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 5, 2014, Pages 2153-2162

  Li, X Xiao ^a   Wang, Qian ^a   Xu, Hua ^b   Tao, Liping ^a   Lu, Jing ^a   Cai, Lin ^a   Wang, Chunhui ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Claudins; IBD; Infectious colitis; Occludin; Somatostatin; Tight junction

Indexed keywords

CLAUDIN 1; CLAUDIN 3; CLDN1 PROTEIN, MOUSE; CLDN3 PROTEIN, MOUSE; DEXTRAN SULFATE; GASTROINTESTINAL AGENT; OCTREOTIDE; SOMATOSTATIN; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CACO 2 CELL LINE; CHEMICALLY INDUCED; CITROBACTER RODENTIUM; COLITIS; COLON; DIARRHEA; DISEASE MODEL; DRUG EFFECTS; ESCHERICHIA COLI; FEMALE; HUMAN; METABOLISM; MICROBIOLOGY; PATHOGENICITY; TIGHT JUNCTION; TIME;

ANIMALS; CACO-2 CELLS; CITROBACTER RODENTIUM; CLAUDIN-1; CLAUDIN-3; COLITIS; COLON; DEXTRAN SULFATE; DIARRHEA; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MICE, INBRED C57BL; OCTREOTIDE; SOMATOSTATIN; TIGHT JUNCTION PROTEINS; TIGHT JUNCTIONS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902497836     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. González-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog Biophys Mol Biol 2003; 81: 1-44.
2. Guttman JA, Li Y, Wickham ME, Deng W, Vogl AW, Finlay BB. Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell Microbiol 2006; 8: 634-45.
3. Guttman JA, Finlay BB. Tight junctions as targets of infectious agents. Biochim Biophys Acta 2009; 1788: 832-841.
4. Zeissig S, Bürgel N, Günzel D, Richter J, Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M, Schulzke JD. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007; 56: 61-72.
5. Vetrano S, Rescigno M, Cera MR, Correale C, Rumio C, Doni A, Fantini M, Sturm A, Borroni E, Repici A, Locati M, Malesci A, Dejana E, Danese S. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology 2008; 135: 173-184.
6. Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009; 58: 196-201.
7. Mazzon E, Crisafulli C, Galuppo M, Cuzzocrea S. Role of peroxisome proliferator-activated receptor-alpha in ileum tight junction alteration in mouse model of restraint stress. Am J Physiol Gastrointest Liver Physiol 2009; 297: G488-505.
8. McClane BA, Chakrabarti G. New insights into the cytotoxic mechanisms of Clostridium perfringens enterotoxin. Anaerobe 2004; 10: 107-114.
9. Muza-Moons MM, Schneeberger EE, Hecht GA. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cell. Cell Microbiol 2004; 6: 783-93.
10. Gassler N, Rohr C, Schneider A, Kartenbeck J, Bach A, Obermüller N, Otto HF, Autschbach F. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001; 281: G216-228.
11. Marin ML, Greenstein AJ, Geller SA, Gordon RE, Aufses AH Jr. A freeze fracture study of Crohn's disease of the terminal ileum: changes in epithelial tight junction organization. Am J Gastroenterol 1983; 78: 537-547.
12. Olson TS, Reuter BK, Scott KG, Morris MA, Wang XM, Hancock LN, Burcin TL, Cohn SM, Ernst PB, Cominelli F, Meddings JB, Ley K, Pizarro TT. The primary defect in experimental ileitis originates from a nonhematopoietic source. J Exp Med 2006; 203: 541-552.
13. Poritz LS, Garver KI, Green C, Fitzpatrick L, Ruggiero F, Koltun WA. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg Res 2007; 140: 12-19.
14. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 2001; 159: 2001-2009.
15. Wang C, Xu H, Chen H, Li J, Zhang B, Tang C, Ghishan FK. Somatostatin stimulates intestinal NHE8 expression via p38 MAPK pathway. Am J Physiol Cell Physiol 2011; 300: C375-382.
16. Dharmsathaphorn K, Gorelick FS, Sherwin RS, Cataland S, Dobbins JW. Somatostatin Decreases Diarrhea in Patients with the Short-Bowel Syndrome. J Clin Gastroenterol 1982; 4: 521-524.
17. Lewin MJ. The somatostatin receptor in the GI tract. Annu Rev Physiol 1992; 54: 455-468.
18. Vockel M, Breitenbach U, Kreienkamp HJ, Brandner JM. Somatostatin regulates tight junction function and composition in human keratinocytes. Exp Dermatol 2010; 19: 888-894.
19. Deng Q, Li ZL, Lu LR. Somatostatin ameliorates gut mucosal barrier damages in acute necrotizing pancreatitis. Chin J Gen Surg 2000; 15: 752-754.
20. Boshuizen JA, Reimerink JH, Korteland-van Male AM, van Ham VJ, Koopmans MP, Büller HA, Dekker J, Einerhand AW. Changes in Small Intestinal Homeostasis, Morphology, and Gene Expression during Rotavirus Infection of Infant Mice. J Virol 2003; 77: 13005-13016.
21. Guttman JA, Samji FN, Li Y, Deng W, Lin A, Finlay BB. Aquaporins contribute to diarrhoea caused by attaching and effacing bacterial pathogens. Cellular Microbiol 2007; 9: 131-141.
22. Koch TR, Morris VA, Go VLW. Somatostatin in the Idiopathic Inflammatory bowel diseases. Dis Colon Rectum 1988; 31: 198-203.
23. Deng W, Vallance BA, Li Y, Puente JL, Finlay BB. Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol Microbiol 2003; 48: 95-115.
24. Borenshtein D, McBee ME, Schauer DB. Utility of the Citrobacter rodentium infection model in laboratory mice. Curr Opin Gastroenterol 2008; 24: 32-37.
25. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007; 2: 541-546.
26. Poritz LS, Harris LR, Kelly AA, Koltun WA. Increase in the Tight Junction Protein Claudin-1 in Intestinal Inflammation. Dig Dis Sci 2011; 56: 2802-2809.
27. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 2001; 159: 2001-2009.
28. van Bergeijk JD, Wilson JH. Somatostatin in inflammatory bowel disease. Mediators Inflamm 1997; 6: 303-309.
29. A Borthakur A, Gill RK, Hodges K, Ramaswamy K, Hecht G, Dudeja PK. Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level. Am J Physiol Gastrointest Liver Physiol 2006; 290: G30-35.
30. Mashukova A, Wald FA, Salas PJ. Tumor Necrosis Factor Alpha and Inflammation Disrupt the Polarity Complex in Intestinal Epithelial Cells by a Posttranslational Mechanism. Mol Cell Biol 2011; 32: 756-765.